| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $14,821,985 ) (Continued on the next page) |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01DK123079 | Unraveling the Role of NADPH Oxidase in Inflammation-associated Pancreatic Diseases | 000 | 5 | NIH | 5/16/2024 | $331,560 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | H1740195 | Healthy Tomorrows Partnership for Children Program | 01 | 4 | HRSA | 3/13/2024 | $0 |
| 2024 | 2024 | UNIVERSITY OF TEXAS AT EL PASO | 500 W University Ave | El Paso | TX | 79968-0001 | EL PASO | USA | H1740195 | Healthy Tomorrows Partnership for Children Program | 00 | 4 | HRSA | 1/31/2024 | $17,075 |
| 2024 | 2024 | The University of Texas at El Paso | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | M0145373 | Behavioral Health Workforce Education and Training Program | 00 | 4 | HRSA | 6/17/2024 | $480,000 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | U1Q53051 | Geriatrics Workforce Enhancement Program | 00 | 1 | HRSA | 5/23/2024 | $250,000 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | U1Q53051 | Geriatrics Workforce Enhancement Program | 00 | 1 | HRSA | 5/23/2024 | $750,000 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | SC1GM139714 | New Treatments for Chronic Chagas Disease | 001 | 4 | NIH | 6/18/2024 | $37,750 |
| 2024 | 2024 | UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-0001 | EL PASO | USA | SC1GM139714 | New Treatments for Chronic Chagas Disease | 000 | 4 | NIH | 12/5/2023 | $339,750 |
| 2024 | 2024 | UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-0001 | EL PASO | USA | R03CA270815 | Development of a Mouse Model to Study Targeted Therapy to Prevent CNS Invasion by Pediatric T-ALL | 000 | 2 | NIH | 11/2/2023 | $76,750 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | P50MD019494 | UTEP Center for Investigator Training and Community Engagement in Transdisciplinary Minority Health Disparities Research | 000 | 1 | NIH | 7/13/2024 | $690,085 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R21CA283583 | A novel gene-based immunotherapy inducing melanoma destruction | 000 | 1 | NIH | 3/14/2024 | $174,151 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01DA059359 | Sex Differences and The Influence of Ovarian Hormones on the Mechanisms that Promote Nicotine Withdrawal | 000 | 1 | NIH | 2/29/2024 | $453,040 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | U01MD019289 | Evidence-based intervention to improve walking engagement in El Paso, Texas | 005 | 3 | NIH | 6/10/2024 | $100,174 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | U01MD019289 | Evidence-based intervention to improve walking engagement in El Paso, Texas | 004 | 3 | NIH | 3/25/2024 | $875,186 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R16GM149426 | The effects of eating a high fat diet on the therapeutic and abuse-related effects of morphine | 001 | 2 | NIH | 7/15/2024 | $15,136 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R16GM149426 | The effects of eating a high fat diet on the therapeutic and abuse-related effects of morphine | 000 | 2 | NIH | 3/21/2024 | $136,224 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R16GM149379 | Characterization of novel pyrazole compounds with potent anti-cancer activity | 001 | 2 | NIH | 6/18/2024 | $15,136 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R16GM149379 | Characterization of novel pyrazole compounds with potent anti-cancer activity | 000 | 2 | NIH | 3/18/2024 | $136,224 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | U54CA280922 | UTEP FIRST: United Toward Equity and Progress: Faculty Institutional Recruitment for Sustainable Transformation | 000 | 2 | NIH | 6/19/2024 | $4,984,399 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R16AI167830 | In vivo relevance of the Schlafen-mediated innate immune mechanism in flavivirus infection | 000 | 2 | NIH | 5/1/2024 | $154,648 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R16GM149515 | Bilingual discourse comprehension: How is text integration affected by overlap in language? | 001 | 2 | NIH | 6/18/2024 | $15,136 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R16GM149515 | Bilingual discourse comprehension: How is text integration affected by overlap in language? | 000 | 2 | NIH | 3/1/2024 | $136,224 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R16GM145551 | Preventative Biomarkers and Potential Pharmacotherapies for Nicotine Use and Diabetes | 000 | 3 | NIH | 6/27/2024 | $153,500 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R16GM145548 | Genetic dissection of dementia | 001 | 3 | NIH | 5/15/2024 | $99,999 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R16GM145548 | Genetic dissection of dementia | 000 | 3 | NIH | 5/1/2024 | $153,500 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01AA030156 | Stage II Efficacy Trial of a Culturally Informed Brief Intervention to Reduce Alcohol Related Health Disparities and Treatment Inequities among Latinxs | 000 | 3 | NIH | 6/28/2024 | $612,358 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R16GM145552 | Psychological stress susceptibility in juvenile female and male mice | 000 | 3 | NIH | 6/5/2024 | $153,500 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01NS119166 | Astrocytic WNK-SPAK-NKCC1 Cascade in White Matter Astrogliosis and Injury | 001 | 4 | NIH | 7/11/2024 | $23,130 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01NS119166 | Astrocytic WNK-SPAK-NKCC1 Cascade in White Matter Astrogliosis and Injury | 001 | 4 | NIH | 7/11/2024 | $13,667 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01NS119166 | Astrocytic WNK-SPAK-NKCC1 Cascade in White Matter Astrogliosis and Injury | 001 | 4 | NIH | 7/11/2024 | $8,759 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01NS119166 | Astrocytic WNK-SPAK-NKCC1 Cascade in White Matter Astrogliosis and Injury | 000 | 4 | NIH | 3/7/2024 | $331,183 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01NS119166 | Astrocytic WNK-SPAK-NKCC1 Cascade in White Matter Astrogliosis and Injury | 000 | 4 | NIH | 3/7/2024 | $78,829 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | T34GM145529 | U-RISE at the University of Texas at El Paso | 000 | 3 | NIH | 3/27/2024 | $786,920 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | T32GM144919 | G-RISE at the University of Texas at El Paso | 001 | 3 | NIH | 6/27/2024 | $19,997 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | T32GM144919 | G-RISE at the University of Texas at El Paso | 000 | 3 | NIH | 4/22/2024 | $573,809 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R01DA053659 | Optimizing a bio-behavioral intervention to promote viral suppression among HIV+ people who inject drugs on the U.S.-Mexico border | 001 | 4 | NIH | 7/3/2024 | $613,012 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | SC1GM140968 | Development of Drugs to Target Arginine Biosythesis in Mycobacterium tuberculosis | 001 | 4 | NIH | 6/18/2024 | $37,750 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | SC1GM140968 | Development of Drugs to Target Arginine Biosythesis in Mycobacterium tuberculosis | 000 | 4 | NIH | 3/27/2024 | $339,750 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | H79SM084007 | Mental Health Awareness Training for Healthy US-MX Border Minority Communities: Expansion to Rural TX Public Health Region 10 (09/30/21- 09/29/26) | 001 | 4 | SAMHSA | 5/24/2024 | $125,000 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | H1740195 | Healthy Tomorrows Partnership for Children Program | 02 | 4 | HRSA | 6/5/2024 | $32,925 |
| 2024 | 2024 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R25DA033613 | Summer Mentoring and Research in Transdisciplinary Methodologies in Neuroscience of Drug-Addiction (SMART MIND) | 003 | 12 | NIH | 3/21/2024 | $128,327 |
| 2024 | 2023 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | U01MD019289 | Evidence-based intervention to improve walking engagement in El Paso, Texas | 003 | 2 | NIH | 3/5/2024 | $26,384 |
| 2024 | 2023 | UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-0001 | EL PASO | USA | U01MD019289 | Evidence-based intervention to improve walking engagement in El Paso, Texas | 001 | 2 | NIH | 12/19/2023 | $950,910 |
| 2024 | 2023 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | H79SM084281 | The Mental Health Service Provision and Awareness Program ( MHSPAP) | 001 | 1 | SAMHSA | 5/15/2024 | $0 |
| 2024 | 2023 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | H79SM084281 | The Mental Health Service Provision and Awareness Program ( MHSPAP) | 001 | 1 | SAMHSA | 5/15/2024 | $0 |
| 2024 | 2023 | UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-0001 | EL PASO | USA | H79SM084281 | The Mental Health Service Provision and Awareness Program ( MHSPAP) | 000 | 1 | SAMHSA | 12/6/2023 | $0 |
| 2024 | 2023 | UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-0001 | EL PASO | USA | H79SM084281 | The Mental Health Service Provision and Awareness Program ( MHSPAP) | 000 | 1 | SAMHSA | 12/6/2023 | $0 |
| 2024 | 2023 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | R21CA264627 | The role of tumor endothelium-specific prion-gene PRND in epithelial ovarian cancer | 000 | 2 | NIH | 6/27/2024 | -$173,854 |
| 2024 | 2023 | THE UNIVERSITY OF TEXAS AT EL PASO | 500 W UNIVERSITY AVE | EL PASO | TX | 79968-8900 | EL PASO | USA | SC1GM144171 | Priming pancreatic ductal adenocarcinoma using blood thinners to sensitize the efficacy of checkpoint immunotherapy | 000 | 2 | NIH | 7/1/2024 | $0 |
|